Ambagon Therapeutics

Ambagon Therapeutics

    Company info:

  • 1-50
  • 2020
  • San Francisco, CA
  • 100-500M


ambagontx.com

linkedin.com


Claim company profile

About company:

Ambagon Therapeutics is enhancing the activity of tumor suppressors by creating cancer molecule therapeutics. 14-3-3 proteins are adaptor proteins that play a key role in a large number of disease-related pathways, but are intrinsically disordered, making it hard to design small molecule binders. However, these disordered regions become ordered when 14-3-3 binds other “client” protein interactors. Different clients create structurally unique pockets on 14-3-3 enabling Ambagon to develop small molecules that can stabilize specific 14-3–3:client interactions. Ambagon has built an extensive database of 14-3-3:client protein structures to quickly identify the most promising candidates for screening. Amabagon now has five programs in early discovery and expects one to reach development by 2023.

Jobs:

Ambagon Therapeutics
All jobs
See jobs

Claim company profile to post jobs directly on this page and this website.


© 2023 Work In Biotech LLC
Personal data

Terms of Service

Privacy Policy

Contact: recruit@workinbiotech.com